Defu Capital
VC Fund
Defu Capital is an investment firm.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Defu Capital invests in
Stages Defu Capital invests in
Countries Defu Capital invests in
Investment Focus
Industry
- Medical 1 (33%)
- Genetics 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
Stage
- Series A 1 (33%)
- Series C 1 (33%)
- Venture - Series Unknown 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sangon Biotech
|
Sangon Biotech Co. (生工生物) is engaged in the research and development of chemical synthesis of DNA.It is a high-tech Sino-foreign joint venture established in 2003. After ten years of development, Sangon has become a professional biotechnology company that integrates research and development. Chemical synthesis DNA earned reputation for Sangonin the global market.In 2006, Sangon invested 50 million to build a manufacturing and industrial base in Songjiang Industrial Park, which has been put into use. Sangon produces various products such as DNA synthesis, DNA sequencing, Gene Synthesis, peptide synthesis, chemical agents, enzymes, molecular biology kit, cultivation medium, lab consumptive material, and miniature instruments. | $290.4M / Venture - Series Unknown / Apr 19, 2023 | |
Nest
|
Nest Bio is a manufacturer of disposable medical consumables, focusing on the R&D and production of cell culture consumables. | Series A / Jun 07, 2022 | |
Bohai New Enzyme
|
Bohai New Enzyme is a special enzyme research and development manufacturer. | $125M / Series C / Nov 05, 2021 |
Co-Investors
CASH Capital
1 deal together
China Pacific Insurance
1 deal together
CPE
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Defu Capital invest in?
Defu Capital invests primarily in Medical, Genetics and Health Care startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Defu Capital last invest?
The most recent investment recorded for Defu Capital closed in Apr 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
